| 저자 |
Tai Yeon Koo1, Ji-Jing Yan2, Jong Cheol Jeong1, Eunwon Lee2,Bohae Kang2, Kyu Hyun Han2, Curie Ahn3, Jaeseok Yang |
| 초록 |
Background: Extracellular adenosine triphosphate (ATP)
plays a crucial role in promoting inflammatory immune
responses. The extracellular ATP can stimulate effector T
cells as a costimulatory signal through P2X receptor, and
oxidized ATP (oATP), a P2X receptor antagonist, can
induce regulatory T cells (Tregs). Tregs can suppress
inflammatory
processes and thereby renal injury in ischemia-perfusion
injury (IRI). Here, we investigated whether oATP can
attenuate renal IRI by inducing Tregs in murine models.
Methods: Male C57BL/6 mice, 6-8 weeks old, were used
in both prevention and treatment models. The core
temperature
was maintained at 37℃ with heating pad, and both renal
pedicles were clamped for 28 minutes. oATP or
PBS was administered intraperitoneally to the mice for 7
consecutive days beginning 6 days before IRI, or 4
consecutive
days beginning 1 day after IRI. Serum blood urea nitrogen
(BUN) and creatinine (Cr) were measured to
assess kidney function. Flow cytometric analysis of
spleen and kidney cells was conducted. Renal
inflammation was
assessed using immunohistochemical staining and tissue
cytokine quantification.
Results: Low-dose multiple injection of oATP induced
more CD4+CD25+ Tregs than high-dose once injection of
oATP
(p=0.001), and therefore we chose low-dose multiple
injection of oATP in order to induce Tregs. In the
prevention
model, oATP induced significant expansion of CD4+CD25+
Tregs in the spleen (p=0.009). Both serum BUN and Cr
were significantly lower in the oATP group than in the PBS
group (p=0.001 and p<0.001, respectively). Both tubular
injury score and tubular epithelial cell apoptosis after IRI
were significantly lower in the oATP group than in the PBS
group (p<0.001 and p=0.001, respectively). oATP also
significantly attenuated the infiltration of both neutrophil
and
macrophage into the renal tissue after IRI (p<0.001 for
both), and decreased the expression of both IL-6 and
CCL2
(p=0.021 for both). In the treatment model, oATP induced
significantly expansion of CD4+CD25+ Tregs in the spleen
and kidney (p<0.001 and p=0.016, respectively). Renal
function on day 5 was significantly better in the oATP
group
than the PBS group (p=0.005 and p=0.007, respectively). In
addition, renal tubular cell proliferation on day 5 was
significantly increased by oATP (p=0.013).
Conclusion: oATP can attenuate acute renal damage, and
improve renal recovery in IRI by inducing Tregs. |